MedPath
HSA Approval

ERMYCIN 250 TABLET 250 mg

SIN07545P

ERMYCIN 250 TABLET 250 mg

ERMYCIN 250 TABLET 250 mg

November 1, 1993

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01FA01

erythromycin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD (BUILDING 1- GENERAL PRODUCTS)

Active Ingredients

ERYTHROMYCIN STEARATE EQV ERYTHROMYCIN

250 mg

Erythromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.